Journey Medical Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
DERM Nasdaq 2834 journeymedicalcorp.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Journey Medical Corporation

Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome Data - Jan 8th, 2026 12:00 pm
Public companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33% - Dec 22nd, 2025 5:33 am
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology - Dec 10th, 2025 6:30 am
What Makes Journey Medical Corporation (DERM) a Good Investment? - Nov 19th, 2025 6:18 am
Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Nov 17th, 2025 6:06 pm
Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics - Nov 12th, 2025 4:30 pm
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 3:15 pm
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - Nov 12th, 2025 2:01 pm
electroCore, Inc. (ECOR) Reports Q3 Loss, Beats Revenue Estimates - Nov 5th, 2025 4:35 pm
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 - Nov 5th, 2025 6:30 am
OmniAb, Inc. (OABI) Reports Q3 Loss, Misses Revenue Estimates - Nov 4th, 2025 4:35 pm
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference - Oct 24th, 2025 6:30 am
Journey Medical Corporation to Participate in October 2025 Investor Conferences - Oct 8th, 2025 6:30 am
Summers Value Partners’ Update on Journey Medical (DERM) - Sep 22nd, 2025 7:03 am
Journey Medical Corporation to Participate in September 2025 Investor Conferences - Sep 3rd, 2025 6:30 am
A Look At The Intrinsic Value Of Journey Medical Corporation (NASDAQ:DERM) - Aug 25th, 2025 6:10 am
Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream - Aug 19th, 2025 5:00 am
Journey Medical Corporation to Present at the Emerging Growth Conference - Aug 18th, 2025 6:30 am
Journey Medical Corp (DERM) Q2 2025 Earnings Call Highlights: Strong Arosi Launch Drives ... - Aug 13th, 2025 5:00 pm
Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates - Aug 12th, 2025 3:15 pm